The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Cronos Group (CRON) is a stock that can certainly grab the ...

This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return potential, read our free article: 10 Promising SmallCap Stocks Under $1 Billion ...

Cronos Group operates in a highly competitive industry but has a marked advantage over its peers owing to its vastly superior ...

CRON's financials show strong liquidity with a sequential increase in cash and cash equivalents, no debt, and positive free cash flow. Despite unprofitability, CRON's assets dwarf liabilities, and it ...

The average one-year price target for Cronos Group (NASDAQ:CRON) has been revised to 2.61 / share. This is an increase of 5.54% from the prior estimate of 2.47 dated October 31, 2023. The price target ...

) has been revised to $3.62 / share. This is an increase of 104.89% from the prior estimate of $1.77 dated June 20, 2025. The price target is an average of many targets provided by analysts. The ...

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment ...

Cronos Group Inc (NASDAQ:CRON) is trading higher Monday following reports of a Republican-led marijuana legalization bill. According to reports from Marijuana Moment, the bill is a compromise between ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Cronos Group (CRON) is a stock that can certainly grab the ...